KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Endava (DAVA) Cash & Equivalents (2017 - 2025)

Historic Cash & Equivalents for Endava (DAVA) over the last 9 years, with Q3 2025 value amounting to $80.1 million.

  • Endava's Cash & Equivalents fell 118.8% to $80.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $80.1 million, marking a year-over-year decrease of 118.8%. This contributed to the annual value of $79.2 million for FY2025, which is 6699.21% down from last year.
  • Endava's Cash & Equivalents amounted to $80.1 million in Q3 2025, which was down 118.8% from $79.2 million recorded in Q2 2025.
  • In the past 5 years, Endava's Cash & Equivalents registered a high of $251.9 million during Q1 2024, and its lowest value of $78.5 million during Q1 2025.
  • In the last 5 years, Endava's Cash & Equivalents had a median value of $153.2 million in 2022 and averaged $155.8 million.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first surged by 10989.59% in 2022, then tumbled by 6882.47% in 2025.
  • Endava's Cash & Equivalents (Quarter) stood at $94.2 million in 2021, then surged by 102.71% to $191.0 million in 2022, then grew by 7.05% to $204.4 million in 2023, then tumbled by 60.85% to $80.0 million in 2024, then rose by 0.03% to $80.1 million in 2025.
  • Its Cash & Equivalents stands at $80.1 million for Q3 2025, versus $79.2 million for Q2 2025 and $78.5 million for Q1 2025.